EU approves $13 billion Biomet-Zimmer merger

Zimmer Holdings secures approval in the European Union for its $13 billion acquisition of fellow orthopedic-device maker Biomet after agreeing to sell three businesses in Europe to assuage antitrust concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.